Takeda expands covid-19 vaccine supply in japan through partnership with moderna and government of japan

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tse:4502/nyse:tak), announced today that it will import and distribute 50 million doses of moderna's covid-19 vaccine candidate, mrna-1273, starting in the first half of 2021, pending licensure in japan. this effort is part of a three-way agreement among takeda, moderna and the government of japan's ministry of health labour and welfare (mhlw). moderna has previously announced that the 30,000 participant phase 3 clinical tria
TAK Ratings Summary
TAK Quant Ranking